Search

everythinglearnresearchcommunity

for

Search:↓

Stress increases neurosteroids that help prevent seizures.

Niosomes are a promising, stable, and cost-effective drug delivery system with potential for improved targeting and safety.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Mechanical stretching of the skin can promote hair growth by activating certain immune cells.

Using CDK inhibitors on rats showed a reduction in chemotherapy-caused hair loss, but later experiments could not repeat these results.

Nanoparticles improve drug delivery through the skin but more research is needed on their long-term effects and skin penetration challenges.

Liposomal systems show promise for delivering drugs through the skin but face challenges like high costs and stability issues.

Minoxidil shortens baldness from chemotherapy by 50.2 days without significant side effects.

Macrophages help regrow hair by activating stem cells using AKT/β-catenin and TNF.

Chemotherapy often causes temporary hair loss, which is distressing and needs better treatment and support.

All-trans retinoic acid causes hair loss by increasing TGF-β2 in hair follicle cells.

The conclusion is that hair growth can be improved by activating hair cycles, changing the surrounding environment, healing wounds to create new hair follicles, and using stem cell technology.

Advanced nanocarrier and microneedle drug delivery methods are more effective, safer, and less invasive for treating skin diseases.

Hair greying is caused by oxidative stress damaging hair follicles and melanocytes.

Some chemotherapy can cause permanent hair loss.

Microneedle technology has improved drug delivery and patient comfort but needs more research for broader use.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

PEGL-DOX causes Hand-Foot Syndrome due to skin reactions from prolonged circulation and ROS generation.

Scalp cooling can reduce chemotherapy-induced hair loss and should be available in all hospitals.

Both mouse and rat models are effective for testing alopecia areata treatments.

Minoxidil not effective in preventing chemotherapy-induced hair loss.

Many patients find hair loss from chemotherapy very distressing, and while treatments like minoxidil and scalp cooling may help, there is no sure way to prevent it.

Low-level laser treatment helped rats regrow hair faster after chemotherapy.

Long-term minoxidil use can cause pseudoacromegaly, but stopping it improves symptoms.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.

Using a gene therapy with the Sonic Hedgehog gene helps mice regrow hair faster after losing it from chemotherapy.

The study concludes that the EDA2R gene is activated by p53 during chemotherapy but is not necessary for chemotherapy-induced hair loss.

A study found that minoxidil can damage the hearts of dogs and pigs, cautioning its use in humans.

Chemotherapy can cause hair changes similar to alopecia areata, which might lead to misdiagnosis.